GoldenTree: Kashiv BioSciences: $150 Million Debt Financing Raised From GoldenTree Asset Management
Kashiv BioSciences, a fully integrated biopharmaceutical company, announced that it has entered a senior secured credit agreement with GoldenTree Asset Management as the sole lender. The post Kashiv BioSciences: $150 Million Debt Financing Raised From GoldenTree Asset Management appeared first on Pulse 2.0.
Read full article »
GoldenTree is a New York-based asset management firm that provides services such as private credit and digital asset strategy for institutional investors.
Read more